Tranexamic acid reduces surgical transfusions without raising clot risks

This pan-Canadian clinical trial studied over 8,000 major surgeries to determine if tranexamic acid reduced bleeding and blood transfusion without increasing the risk of clots. The results of the trial support expanding its use to all major surgeries where patients face a high risk of blood loss.

Universal adoption of the drug also has the potential to save significant money.

Source:

The Ottawa Hospital

Journal reference: